Gozlan Lawrence Bernard
Transaction: 06/15/2026
BUY
Change
+1,000,000
Price
$1.00
Filing
06/23/2026
Type
BUY
Alterity Therapeutics Limited
ATHE • Biotechnology
$4.52
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$81.93M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 14.52Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 30, 2026, 12:07 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$4.52
Change0.00%
Shares Out18.13M
Market Cap$81.93M
52W Range2.66 - 5.89
Beta-0.03
P/E-5.89
P/S0.00
P/B3.19
P/FCF0.00
EV/Sales0.00
EV/EBITDA-3.58
Price$4.52
Change0.00%
Shares Out18.13M
Market Cap$81.93M
52W Range2.66 - 5.89
Beta-0.03
P/E-5.89
P/S0.00
P/B3.19
P/FCF0.00
EV/Sales0.00
EV/EBITDA-3.58
EV/FCF0.00
Earnings Yield-16.78%
FCF Yield0.00%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio14.52
Quick Ratio14.52
Target$7.00
Target Upside54.87%
Target Median$7.00
Target Range2.00 - 12.00
Volume11.65K
Avg Volume38.41K
EPS Surprise-0.15
Investment DNA
How strong this company looks for long-term investors
36
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
77/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 14.52Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 8 analyst votes · 2026-09-04
75/100
Bullish
Bullish
4
Hold
4
Bearish
0
Price Target
2026-08-30
Low
$2.00
Mean
$7.00
Median
$7.00
High
$12.00
Insider Transactions
Recent executive and insider activity
Babarczy Julian Michael
Transaction: 06/15/2026
BUY
Change
+2,000,000
Price
$1.00
Filing
06/23/2026
Type
BUY
Cunningham Ann Michelle
Transaction: 04/17/2026
OTHER
Change
0
Price
Not reported
Filing
04/29/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Gozlan Lawrence Bernard | BUY | +1,000,000 | $1.00 | 06/15/2026 | 06/23/2026 |
| Babarczy Julian Michael | BUY | +2,000,000 | $1.00 | 06/15/2026 | 06/23/2026 |
| Cunningham Ann Michelle | OTHER | 0 | Not reported | 04/17/2026 | 04/29/2026 |
| Stamler David Allen | OTHER | +40,000,200 | $0.00 | 04/15/2026 | 04/15/2026 |
| Stamler David Allen | OTHER | +1,515,152 | $0.03 | 04/15/2026 | 04/15/2026 |
| Stamler David Allen | OTHER | +2,380,952 | $0.01 | 04/15/2026 | 04/15/2026 |
| Stamler David Allen | OTHER | +290,400,000 | $0.01 | 04/15/2026 | 04/15/2026 |
| Stamler David Allen | OTHER | 0 | Not reported | 04/15/2026 | 04/15/2026 |
| Stamler David Allen | OTHER | 0 | Not reported | 04/15/2026 | 04/15/2026 |
| Marks Peter Ashley | OTHER | +30,000,000 | $0.01 | 04/10/2026 | 04/10/2026 |
| Marks Peter Ashley | OTHER | +606,061 | $0.03 | 04/10/2026 | 04/10/2026 |
| Marks Peter Ashley | OTHER | 0 | Not reported | 04/10/2026 | 04/10/2026 |
| Babarczy Julian Michael | OTHER | 0 | Not reported | 04/10/2026 | 04/10/2026 |
| Gozlan Lawrence Bernard | OTHER | +50,000,000 | $0.01 | 04/10/2026 | 04/10/2026 |
| Gozlan Lawrence Bernard | OTHER | +1,515,152 | $0.03 | 04/10/2026 | 04/10/2026 |
| Gozlan Lawrence Bernard | OTHER | 0 | Not reported | 04/10/2026 | 04/10/2026 |
| Macnish Niven Abby Sarah | OTHER | +151,510 | $0.03 | 04/10/2026 | 04/09/2026 |
| Macnish Niven Abby Sarah | OTHER | 0 | Not reported | 04/09/2026 | 04/09/2026 |